|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.4 AUD | +17.65% |
|
+321.05% | -39.39% |
| Apr. 23 | Australian Shares Rise on Business Activity Growth; Osteopore Soars 127% | MT |
| Apr. 23 | Osteopore Commences In-Human Clinical Trials for Knee Preservation; Shares Surge 194% | MT |
Osteopore Limited reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was AUD 0.997102 million compared to AUD 0.816127 million a year ago. Net loss was AUD 2.98 million compared to AUD 1.95 million a year ago.
Basic loss per share from continuing operations was AUD 0.288 compared to AUD 0.249 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -39.39% | 2.69M | |
| -2.31% | 187B | |
| -3.20% | 106B | |
| -5.04% | 66.9B | |
| +0.20% | 49.45B | |
| +17.29% | 48B | |
| +4.06% | 40.84B | |
| +2.07% | 26.48B | |
| +2.36% | 26.25B | |
| +12.96% | 24.62B |
OSTEOPORE LIMITED 
